跳至主要内容
临床试验/ITMCTR2100005422
ITMCTR2100005422尚未招募未知

Clinical and mechanism study of Wa medicine Yiqi Tongluo recipe regulating HIF-1 / VEGF & EPO pathway to alleviate tissue hypoxia in the treatment of diabetic peripheral neuropathy

Yunnan Traditional Chinese medicine hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • ? Diagnostic criteria for western medicine: guideline for prevention and treatment of type 2 diabetes mellitus (2021 Edition) published by China Diabetes Association of Chinese Medical Association. A. has a clear history of diabetes mellitus; B. diagnosed diabetic neuropathy; or C., clinical symptoms and signs are consistent with DPN's performance; D. has clinical symptoms (pain, numbness, abnormal sensation, etc.); E.5 examination. (ankle reflex, acupuncture pain, vibration, pressure and temperature) is abnormal in any one item; if there are no clinical symptoms, any two of the five items are abnormal, and the clinical diagnosis is DPN.
  • ? The diagnostic criteria of TCM syndromes: refer to the guidelines for the diagnosis and treatment of diabetic peripheral neuropathy combined with the 2021 issue of Endocrinology and metabolic diseases of Chinese Medical Doctor Association integrated traditional Chinese and Western medicine physicians' branch. The standard clinical manifestations of DPN patients with Qi deficiency and blood stasis type: A. meet the clinical symptoms and signs of Xiaoke Bi syndrome, numbness of hands and feet, pain at the end of limbs, mostly tingling, mainly lower limbs, and very painful at night; b. Qi deficiency syndrome: mental fatigue, shortness of breath, lazy speech, movement leads to sweating; c. Qi deficiency and blood stasis tongue pulse: the tongue is light and dark, or there are ecchymosis spots, the moss is thin and white, and the pulse is thin and astringent.
  • ? The age range is 20-70 years old, regardless of gender.
  • ? Informed consent, voluntary subjects, the process of obtaining informed consent was in accordance with the provisions of GCP.

排除标准

  • ? Abnormal liver and kidney function, blood Cr, alt, AST and BUN exceeding the normal value by more than 2.5 times.
  • ? Patients with hypertension not effectively controlled, serious heart, brain, liver, kidney and other organ diseases, as well as blood system diseases or tumors.
  • ? Take the following drugs, such as Danshen dropping pills, puerarin, Astragalus and other traditional Chinese medicine preparations, western drugs containing hormones and drugs containing the above ingredients.
  • ? After the onset of this disease, other Chinese patent medicines for supplementing qi and activating blood circulation for the treatment of DNP are being used.
  • ? Patients whose blood glucose and other indicators significantly exceed the average level of the study object, or receive other unconventional treatment, which may seriously interfere with the baseline level of the study object.
  • ? Pregnant and lactating women.
  • ? Allergic constitution, etc.
  • ? A mentally or legally disabled person.
  • ? Suspected or true history of alcohol and drug abuse, or other diseases that reduce the possibility of enrollment or complicate enrollment according to the judgment of the researcher, such as frequent changes in working environment, which are easy to cause loss of follow-up.

研究者

发起方
Yunnan Traditional Chinese medicine hospital

相似试验